Abu Dhabi Doctors Successfully Diagnose and Treat One-in-a-Million Rare Disease  

Stay Updated with the Latest Developments at Burjeel Medical City

Abu Dhabi Doctors Successfully Diagnose and Treat One-in-a-Million Rare Disease  

Abu Dhabi Doctors Successfully Diagnose and Treat One-in-a-Million Rare Disease  

The patient, treated at Burjeel Hospital, Abu Dhabi, suffered from Adult-Onset Still’s Disease (AOSD), a rare autoimmune condition affecting approximately 1–4 people per million worldwide 

Abu Dhabi: The 34-year-old patient residing in Abu Dhabi had always enjoyed robust health. So, when persistent high-grade fever plagued him for more than two weeks, it was deeply unsettling for him. Despite multiple hospital visits and extensive routine testing, including blood cultures and standard infection screens, the cause of his illness remained unknown, intensifying worries as his condition continued to worsen. With fever, disabling joint pain, extreme fatigue, and evidence of intense inflammation, and liver involvement, his condition started to raise concern as he began to show signs of a potentially life-threatening illness. 

Although he looked stable, the severity and persistence of his symptoms were alarming, prompting the medical team at Burjeel Hospital, Abu Dhabi, to intervene urgently. An in-depth investigation revealed that he was affected by Adult-Onset Still’s Disease (AOSD), a rare autoimmune condition affecting approximately 1–4 people per million worldwide. 

A Difficult-to-Diagnose Disorder  

Dr. Niyas Khalid, Specialist, Internal Medicine, says AOSD is extremely difficult to diagnose because of its rarity and resemblance to other infections. “It mimics many life-threatening diseases such as severe infections, autoimmune disorders, liver disease, and even cancer. It’s often under-recognized, particularly in regions where fever is commonly attributed to infectious causes,” says Dr. Niyas, who treated the patient along with Dr. Abdul Hakeem Muhammed, Specialist, Internal Medicine.  

At the hospital, the patient underwent a series of tests to rule out other possibilities. A major challenge was his body not having rashes, a feature often described in textbooks, but frequently absent or difficult to detect in individuals with darker complexion, adds the doctor.  

In his case, what stood out was the unique combination of prolonged fever, severe inflammation, liver involvement, and extremely high ferritin levels. In addition, all infectious and autoimmune tests had returned negative. “The extraordinarily elevated ferritin, a marker of inflammation, acted as a critical diagnostic signal. When these features came together, along with high-grade fever spiking every day at regular intervals, AOSD became the most plausible explanation, although it is extremely rare,” says Dr. Niyas. 

Fatal if Not Diagnosed in Time 

When affected by AOSD, the patient’s immune system becomes overactive and attacks itself, causing widespread inflammation. If not diagnosed and treated at the right time, the disease can progress to severe complications such as organ damage, chronic inflammatory arthritis, liver failure, or a potentially fatal immune storm known as macrophage activation syndrome. In this case, early intervention was life-altering and, potentially, life-saving. 

“During those days, I shivered from fever and struggled to get up from bed, lift my hands, and move my body. There was no appetite because of throat pain. Despite taking medicine, my fever recurred, draining me emotionally. I prayed to God to give my routine life back,” recalls the patient. 

Rapid Return to Normalcy  

Once AOSD was suspected, the medical team initiated high-dose corticosteroid therapy, the cornerstone treatment for this condition. After the initial high doses, the steroid was tapered carefully over several weeks to suppress the immune reaction while allowing safe recovery. “Within 24 hours, the fever subsided. Within 48 hours, the patient felt significantly better, with improvement in joint pain and energy levels. Laboratory markers improved in parallel,” explains Dr. Niyas. 

“I am so happy that I can move my body without support for the first time after a while. Everyone in the hospital gave me hope whenever I doubted, got frustrated, and questioned myself,” says the patient. 

Although he has recovered remarkably well, ongoing follow-up is essential as AOSD can recur in some patients. He will continue regular follow-up with internal medicine and rheumatology to monitor any signs of relapse and ensure long-term stability. 

Burjeel Holdings and UK-Based Avatrial Join Hands to Develop First-of-Its-Kind AI-Powered Cancer Drug Discovery Ecosystem in Abu Dhabi 

Burjeel Holdings and UK-Based Avatrial Join Hands to Develop First-of-Its-Kind AI-Powered Cancer Drug Discovery Ecosystem in Abu Dhabi 

Signed at the Abu Dhabi Future Health Summit, the UK–UAE collaboration aims

Learn More
Burjeel Cancer Institute in Abu Dhabi introduces targeted radiopharmaceutical therapy for certain metastatic tumours 

Burjeel Cancer Institute in Abu Dhabi introduces targeted radiopharmaceutical therapy for certain metastatic tumours 

Abu Dhabi, 16 October 2026: Burjeel Cancer Institute has introduced therapeutic radiopharmaceuticals

Learn More
Global Hematology Pioneer Prof. Alok Srivastava to Build International Hematology Institute in UAE 

Global Hematology Pioneer Prof. Alok Srivastava to Build International Hematology Institute in UAE 

The Institute being developed by Burjeel Holdings will strengthen advanced care for

Learn More
Four Burjeel Professors Named Among the World’s Top 2% Most Cited Scientists in 2026 Stanford–Elsevier Database  

Four Burjeel Professors Named Among the World’s Top 2% Most Cited Scientists in 2026 Stanford–Elsevier Database  

International recognition highlights Burjeel’s growing contribution to scientific research across oncology, hematology,

Learn More
Burjeel Holdings Unifies LLH, Lifecare, and Medeor to Accelerate Affordable Healthcare Growth 

Burjeel Holdings Unifies LLH, Lifecare, and Medeor to Accelerate Affordable Healthcare Growth 

Dedicated platform brings together brands contributing more than 20% of Group revenue,

Learn More
Burjeel Cancer Institute Designated Centre of Excellence for Breast Cancer by Department of Health – Abu Dhabi 

Burjeel Cancer Institute Designated Centre of Excellence for Breast Cancer by Department of Health – Abu Dhabi 

Recognition highlights the Institute’s comprehensive breast cancer program, accelerated diagnostic pathway, advanced

Learn More
Burjeel Holdings Establishes Dedicated Day Surgery Platform to Drive Regional Expansion; Appoints Leadership Team 

Burjeel Holdings Establishes Dedicated Day Surgery Platform to Drive Regional Expansion; Appoints Leadership Team 

Dedicated platform supports day surgery expansion across the UAE and Saudi Arabia. 

Learn More
Burjeel Cancer Institute’s Mobile Mammography Truck to Travel across Abu Dhabi to Promote Early Breast Cancer Detection 

Burjeel Cancer Institute’s Mobile Mammography Truck to Travel across Abu Dhabi to Promote Early Breast Cancer Detection 

BCI was recently designated by the Department of Health – Abu Dhabi

Learn More
Call Now Appointment